Conjunctival autograft for pterygium surgery: how well does it prevent recurrence?

A randomized controlled prospective study to assess the role of subconjunctival bevacizumab in primary pterygium surgery in Indian patients. Indian J Ophthalmol (2015) 1.42

Amniotic membrane graft for primary pterygium: comparison with conjunctival autograft and topical mitomycin C treatment. Br J Ophthalmol (2000) 1.37

Randomised controlled study of conjunctival autograft versus amniotic membrane graft in pterygium excision. Br J Ophthalmol (2006) 1.17

Mitomycin C for pterygium: long term evaluation. Br J Ophthalmol (2004) 0.87

Mitomycin C and conjunctival autograft for recurrent pterygium. Int Ophthalmol (2007) 0.81

Efficacy of Limbal-conjunctival Autograft Surgery with Stem Cells in Pterygium Treatment. Middle East Afr J Ophthalmol (2009) 0.79

Conjunctival autograft for pterygium surgery: how well does it prevent recurrence? Ophthalmic Surg Lasers (1997) 0.79

Long-term follow-up of transplantation of preserved limbal allograft and amniotic membrane for recurrent pterygium. Graefes Arch Clin Exp Ophthalmol (2016) 0.75

Spectrum of fungal keratitis at Wills Eye Hospital, Philadelphia, Pennsylvania. Cornea (2000) 2.85

The indications for and outcome in pediatric keratoplasty. A multicenter study. Ophthalmology (1995) 2.41

Conjunctival necrosis following the administration of subconjunctival corticosteroid. Ophthalmic Surg Lasers (1998) 1.98

Corneal dystrophies. II. Endothelial dystrophies. Surv Ophthalmol (1979) 1.90

Clear corneal wound infection after phacoemulsification. Arch Ophthalmol (2001) 1.83

Anterior chamber cleavage syndrome. A stepladder classification. Surv Ophthalmol (1975) 1.78

Corneal ulcers associated with contact lens wear. Arch Ophthalmol (1984) 1.70

Tarsorrhaphy: clinical experience from a cornea practice. Cornea (2001) 1.66

Corneal dystrophies. I. Dystrophies of the epithelium, Bowman's layer and stroma. Surv Ophthalmol (1978) 1.65

Acute hydrops in the corneal ectasias: associated factors and outcomes. Trans Am Ophthalmol Soc (1999) 1.64

Corneal epithelial wound healing. Br J Ophthalmol (1994) 1.60

Histopathologic evaluation of stromal inflammation in Acanthamoeba keratitis. CLAO J (1994) 1.56

Clinically atypical granular corneal dystrophy with pathologic features of lattice-like amyloid deposits. A study of these families. Ophthalmology (1988) 1.55

Vortex or whorl formation of cultured human corneal epithelial cells induced by magnetic fields. Eye (Lond) (1996) 1.54

Use of routine antibiotic sensitivity testing for the management of corneal ulcers. Arch Ophthalmol (1997) 1.50

Initial treatment of microbial keratitis. CLAO J (1996) 1.50

Corneal transplantation in children with Peters anomaly and mesenchymal dysgenesis. Multicenter Pediatric Keratoplasty Study. Ophthalmology (1997) 1.50

Disorders of the corneal epithelium. A clinicopathologic study of dot, geographic, and fingerprint patterns. Arch Ophthalmol (1974) 1.49

Stability of refraction during four years after radial keratotomy in the prospective evaluation of radial keratotomy study. Am J Ophthalmol (1991) 1.45

Risk factors in microbial keratitis leading to penetrating keratoplasty. Ophthalmology (1999) 1.43

Corneal transplantation in Maroteaux-Lamy syndrome. Arch Ophthalmol (1997) 1.42

Sustained ventricular tachycardia associated with sarcoidosis: assessment of the underlying cardiac anatomy and the prospective utility of programmed ventricular stimulation, drug therapy and an implantable antitachycardia device. J Am Coll Cardiol (1991) 1.41

Subpectoral implantation of cardioverter-defibrillator combined with a nonepicardial lead system: preliminary experience with a novel approach. Am J Cardiol (1993) 1.39

Corneal ulcers and the use of topical fluoroquinolones. CLAO J (1999) 1.39

Management of small corneal infiltrates in contact lens wearers. Arch Ophthalmol (2000) 1.39

Reactivation of herpetic keratitis by epinephrine in rabbit. Arch Ophthalmol (1966) 1.38

Disposable contact lenses: the jury is out. CLAO J (1989) 1.38

Long-term results after penetrating keratoplasty for Fuchs' endothelial dystrophy. Arch Ophthalmol (1996) 1.38

Chalazion-induced hyperopia as a cause of decreased vision. Ophthalmic Surg Lasers (1997) 1.34

Dystrophic changes in the anterior cornea. Arch Ophthalmol (1972) 1.34

Results of the Prospective Evaluation of Radial Keratotomy (PERK) Study five years after surgery. The Perk Study Group. Ophthalmology (1991) 1.33

Diagnosis and management of Acanthamoeba keratitis. Am J Ophthalmol (1985) 1.31

Medical and surgical treatment of Acanthamoeba keratitis. Am J Ophthalmol (1987) 1.30

Corneal complications of topical anesthetic abuse. Can J Ophthalmol (1970) 1.28

Trends in contact lens-associated corneal ulcers. Cornea (1996) 1.27

Late complications in patients with pectoral defibrillator implants with transvenous defibrillator lead systems: high incidence of insulation breakdown. Pacing Clin Electrophysiol (1998) 1.27

Cornea and sclera. Arch Ophthalmol (1972) 1.27

Recurrence of corneal dystrophy after excimer laser phototherapeutic keratectomy. Ophthalmology (1999) 1.26

Ultrasound biomicroscopy as a tool for detecting and localizing occult foreign bodies after ocular trauma. Ophthalmology (1999) 1.26

Sustained symptomatic sinus node reentrant tachycardia: incidence, clinical significance, electrophysiologic observations and the effects of antiarrhythmic agents. J Am Coll Cardiol (1985) 1.24

Familial occurrence of dot (microcystic), map, fingerprint dystrophy of the cornea. Invest Ophthalmol (1975) 1.24

Schirmer's test. A closer look. Arch Ophthalmol (1983) 1.23

Diphtheroids as ocular pathogens. Am J Ophthalmol (1989) 1.22

Clinical indications for and procedures associated with penetrating keratoplasty, 1983-1988. Am J Ophthalmol (1989) 1.20

Chalazion as a cause of decreased vision after LASIK. Cornea (2001) 1.18

Microcystic corneal dystrophy. Trans Am Ophthalmol Soc (1976) 1.16

Factors associated with conjunctival intraepithelial neoplasia: a case control study. Ophthalmic Surg (1990) 1.15

Infected vs sterile corneal infiltrates in contact lens wearers. Am J Ophthalmol (1988) 1.14

IFN-gamma in human Chagas' disease: protection or pathology? Braz J Med Biol Res (1998) 1.13

Corneal thinning in macular corneal dystrophy. Am J Ophthalmol (1986) 1.13

Immunological and clinical evaluation of chagasic patients subjected to chemotherapy during the acute phase of Trypanosoma cruzi infection 14-30 years ago. J Infect Dis (2000) 1.12

Phenol removal onto novel activated carbons made from lignocellulosic precursors: influence of surface properties. J Hazard Mater (2009) 1.12

Sudden death in coronary artery disease: acute ischemia versus myocardial substrate. Circulation (1997) 1.11

Indications for penetrating keratoplasty and associated procedures, 1989-1995. Cornea (1997) 1.11

Corneal melting associated with use of topical nonsteroidal anti-inflammatory drugs after ocular surgery. Arch Ophthalmol (2000) 1.10

Three-year results of the Prospective Evaluation of Radial Keratotomy (PERK) Study. Ophthalmology (1987) 1.10

A new noninvasive index to predict sustained ventricular tachycardia and sudden death in the first year after myocardial infarction: based on signal-averaged electrocardiogram, radionuclide ejection fraction and Holter monitoring. J Am Coll Cardiol (1987) 1.10

Surgical management of pseudophakic corneal edema: complications and visual results following penetrating keratoplasty. Ophthalmic Surg (1982) 1.09